RT Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. Stock: price and insider trades · Canada · SEDISource id SEDI:rakovina-therapeutics-inc-formerly-vincero-capital-corp CA · SEDI Mcap CA$5.1M Track the Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. share price and the full directors' dealings record of the company, a listed issuer based in Canada. Shares are quoted on the CA market, under the authority of SEDI. Market capitalisation: €5.1m. The latest transaction was reported on 26 August 2026 (11 - Acquisition or disposition carried out privately). Among the most active insiders: Prime Global Investment Fund Ltd.. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 August 2026
All Executives20 Thresholds0 Prospectus0 Other0
Declarations 20 total
▲ 1 - Issuer · Executives · 11 Aug 2026
900,000 shares @ CA$0.20 3.81% mcap 50.0% of flow Warrants SEDI:4769084 Canonical exit: 9 Nov 2026 (T+90) ● 1 - Issuer · Executives · 27 Jan 2026
▲ 1 - Issuer · Executives · 11 Aug 2026
1,800,000 shares @ CA$0.10 3.81% mcap 50.0% of flow Common Shares SEDI:4769061 Canonical exit: 9 Nov 2026 (T+90) ● 1 - Issuer · Executives · 27 Jan 2026
Common Shares SEDI:4769060 ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 11 Aug 2026
50,000 shares @ CA$0.20 0.23% mcap 50.0% of flow Warrants SEDI:4763703 Canonical exit: 9 Nov 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 11 Aug 2026
100,000 shares @ CA$0.10 0.23% mcap 50.0% of flow Common Shares SEDI:4763702 Canonical exit: 9 Nov 2026 (T+90) ▲ 3 - 10% Security Holder of Issuer · Executives · 20 Jun 2025
2,430,000 shares Warrants SEDI:4756480 Canonical exit: 18 Sept 2025 (T+90) ▲ 3 - 10% Security Holder of Issuer · Executives · 6 Jun 2025
2,700,000 shares Warrants SEDI:4756478 Canonical exit: 4 Sept 2025 (T+90) ▲ 3 - 10% Security Holder of Issuer · Executives · 6 Jun 2025
Convertible Debentures SEDI:4756475 Canonical exit: 4 Sept 2025 (T+90) ● 3 - 10% Security Holder of Issuer · Executives · 6 Jun 2025
Convertible Debentures SEDI:4756469 ● 3 - 10% Security Holder of Issuer · Executives · 20 Jun 2025
17,100,000 shares Warrants SEDI:4756468 ▲ 3 - 10% Security Holder of Issuer · Executives · 6 Jun 2025
19,000,000 shares @ CA$0.10 Warrants SEDI:4756467 Canonical exit: 4 Sept 2025 (T+90) ● 3 - 10% Security Holder of Issuer · Executives · 6 Jun 2025
● 3 - 10% Security Holder of Issuer · Executives · 20 Jun 2025
17,100,000 shares Common Shares SEDI:4756465 ▲ 3 - 10% Security Holder of Issuer · Executives · 6 Jun 2025
19,000,000 shares @ CA$0.05 Common Shares SEDI:4756464 Canonical exit: 4 Sept 2025 (T+90) ● 3 - 10% Security Holder of Issuer · Executives · 6 Jun 2025
Common Shares SEDI:4756463 ● 3 - 10% Security Holder of Issuer · Executives · 6 Jun 2026
▲ 3 - 10% Security Holder of Issuer · Executives · 6 Jun 2026
1,900,000 shares @ CA$0.50 21.65% mcap 100.0% of flow Common Shares SEDI:4756284 Canonical exit: 4 Sept 2026 (T+90) ● 3 - 10% Security Holder of Issuer · Executives · 6 Jun 2026
Common Shares SEDI:4756283 ● 5 - Senior Officer of Issuer · Executives · 15 Mar 2026
Common Shares SEDI:4747240 关于 Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. Rakovina Therapeutics Inc.，前身为 Vincero Capital Corp.，是一家生物技术公司，专注于开发创新的癌症治疗方法。该公司在 XTSE 上市。